Telo Genomics Corp. Reports Earnings Results for the Third Quarter Ended March 31, 2021
Telo Genomics Corp. announced earnings results for the third quarter ended March 31, 2021. For the third quarter, the company announced net loss was CAD 309,608 compared to CAD 321,422 a year ago. Basic loss per share from continuing operations was CAD 0.01. For the nine months, net loss was CAD 720,783 compared to CAD 907,998 a year ago. Basic loss per share from continuing operations was CAD 0.02 compared to CAD 0.03 a year ago.